...
首页> 外文期刊>Clinical physiology >Comparison of bioimpedance and radioisotope methods in the estimation of extracellular water volume before and after coronary artery bypass grafting operation.
【24h】

Comparison of bioimpedance and radioisotope methods in the estimation of extracellular water volume before and after coronary artery bypass grafting operation.

机译:比较生物阻抗法和放射性同位素法估算冠状动脉搭桥术前后细胞外水量的方法。

获取原文
获取原文并翻译 | 示例
           

摘要

To estimate extracellular water volume (ECW) changes in connection with coronary artery bypass grafting operation, simultaneous ECW estimations by 51Cr-EDTA dilution and whole-body bioimpedance techniques were performed in 15 patients. The assessments of ECW were compared with patients' weighing results. Whole-body bioimpedance-derived ECW correlated significantly with 51Cr-EDTA dilution-based ECW in the pre-operative period (r=0.74; P<0.005); the bias was 0.2 +/- 1.1 l (+/-SD). In the post-operative period, the agreement between these methods was poor, the bias being 0.5 +/- 2.5 l, and no significant correlation between the methods was found (r=0.38; P>0.05). Whole-body bioimpedance-derived ECW changes correlated significantly with weight changes of the patient induced by the operation (r=0.52; P<0.05). 51Cr-EDTA dilution-based ECW changes correlated neither with weight changes (r=0.33; P>0.05) nor with bioimpedance-derived ECW changes (r=0.03; P>0.05). Alterations in radioisotope tracer distribution and loss of it due to blood leakage in the post-operative period were presumed to explain the discrepancy between dilution technique and weighing results. The results suggest that bioimpedance is a useful non-invasive method for assessment of extracellular volume changes induced by coronary artery bypass grafting operations. 51Cr-EDTA dilution-based ECW determination is not suitable in related conditions.
机译:为了估计与冠状动脉旁路移植术相关的细胞外水量(ECW)变化,对15例患者同时进行了51Cr-EDTA稀释和全身生物阻抗技术的ECW估计。将ECW的评估结果与患者的称重结果进行比较。术前全身生物阻抗衍生的ECW与基于51Cr-EDTA稀释的ECW显着相关(r = 0.74; P <0.005);偏差为0.2 +/- 1.1 l(+/- SD)。术后期间,这些方法之间的一致性差,偏差为0.5 +/- 2.5 l,并且发现这些方法之间无显着相关性(r = 0.38; P> 0.05)。全身生物阻抗引起的ECW变化与手术引起的患者体重变化显着相关(r = 0.52; P <0.05)。基于51Cr-EDTA稀释的ECW变化既与重量变化(r = 0.33; P> 0.05)也不相关,也与生物阻抗衍生的ECW变化(r = 0.03; P> 0.05)无关。推测放射性同位素示踪剂分布的变化以及由于术后出血引起的放射性同位素示踪剂的丢失,可以解释稀释技术与称量结果之间的差异。结果表明,生物阻抗是一种有用的非侵入性方法,用于评估冠状动脉搭桥术引起的细胞外体积变化。基于51Cr-EDTA稀释的ECW测定不适用于相关条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号